Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitide versus paclitaxel monotherapy for locally advanced or metastatic breast cancer
ChiCTR-TRC-10001163Phase 2Completed
- Sponsor
- Hefei Anderson Pharmaceutical
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of paclitaxel in breast cancer (2 arms), sponsored by Hefei Anderson Pharmaceutical. Primary endpoints: Objective response rate and Disease control rate. Started Nov 2010; status: completed.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR-TRC-10001163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001163.